Published in Allergy Asthma Clin Immunol on September 15, 2008
Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis. Front Immunol (2016) 0.75
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med (1999) 5.46
Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med (2004) 4.34
Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med (2001) 3.90
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol (2005) 3.48
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (2007) 2.77
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
Role of interleukin 10 in specific immunotherapy. J Clin Invest (1998) 2.57
Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy (2005) 2.55
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy (2003) 2.08
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2007) 2.05
Regulatory T cells in allergy and asthma. Chest (2007) 1.80
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest (1993) 1.66
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol (2007) 1.64
Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy (2001) 1.61
Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol (2004) 1.56
Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy (1999) 1.53
Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy (1996) 1.32
Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol (2004) 1.26
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol (1996) 1.16
Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol (2003) 1.16
Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol (2006) 1.10
Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol (1996) 1.04
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol (2002) 1.03
Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol (2003) 1.00
Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol (2006) 0.96
Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology (1994) 0.94
Mechanisms of allergen specific immunotherapy--T-cell tolerance and more. Allergy (2006) 0.91
Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol (1998) 0.91
Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clin Exp Allergy (2003) 0.90
Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy. Int Arch Allergy Immunol (2006) 0.90
Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol (2007) 0.85
Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy (1995) 0.85
A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol (2001) 0.84
How does sublingual immunotherapy work? J Allergy Clin Immunol (2007) 0.84
Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol (2005) 0.83
Pediatric allergic rhinitis: treatment. Immunol Allergy Clin North Am (2005) 0.77
Immunologic aspects of sublingual immunotherapy in the treatment of allergy and asthma. Curr Med Chem (2007) 0.77
The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients. Clin Exp Allergy (2004) 0.76
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol (2011) 2.06
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2007) 2.05
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol (2009) 2.03
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol (2013) 1.96
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol (2004) 1.92
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med (2008) 1.91
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol (2012) 1.88
Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol (2011) 1.84
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
TH17 cells in the big picture of immunology. J Allergy Clin Immunol (2007) 1.78
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med (2009) 1.57
Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol (2006) 1.45
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol (2013) 1.43
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2013) 1.36
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol (2010) 1.34
Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol (2006) 1.34
The biodiversity hypothesis and allergic disease: world allergy organization position statement. World Allergy Organ J (2013) 1.32
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol (2012) 1.28
T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J (2003) 1.24
Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol (2009) 1.24
Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol (2011) 1.20
Regulatory NK cells suppress antigen-specific T cell responses. J Immunol (2008) 1.18
Immune regulation by histamine. Curr Opin Immunol (2002) 1.16
MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol (2013) 1.16
Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int Arch Allergy Immunol (2005) 1.14
Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol (2003) 1.14
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol (2011) 1.12
T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol (2002) 1.11
TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol (2012) 1.11
Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J Immunol (2009) 1.10
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
T-cell subset regulation in atopy. Curr Allergy Asthma Rep (2011) 1.09
IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol (2011) 1.08
IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol (2007) 1.08
Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res (2010) 1.07
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J Immunol (2009) 1.04
Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol (2005) 1.03
Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J Allergy Clin Immunol (2008) 1.03
Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest (2014) 1.03
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol (2011) 1.01
Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep (2013) 1.01
Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol (2012) 0.99
Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol (2012) 0.98
Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol (2013) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. J Allergy Clin Immunol (2009) 0.97
The role of histamine in regulation of immune responses. Chem Immunol Allergy (2006) 0.95
Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol (2011) 0.95
Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol (2006) 0.94
Apoptosis in tissue inflammation and allergic disease. Curr Opin Immunol (2004) 0.93
Mechanisms of immune tolerance to allergens. Chem Immunol Allergy (2012) 0.93
Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol (2012) 0.93
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. J Allergy Clin Immunol (2012) 0.93
RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter. J Immunol (2010) 0.92
T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy (2008) 0.92
MicroRNAs in allergy and asthma. Curr Allergy Asthma Rep (2014) 0.91
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol (2005) 0.91
Dual nature of T cell-epithelium interaction in chronic rhinosinusitis. J Allergy Clin Immunol (2009) 0.91
Portrait of an immunoregulatory Bifidobacterium. Gut Microbes (2012) 0.91
T regulatory cells in allergy. Chem Immunol Allergy (2006) 0.90
Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol (2015) 0.90